Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tonino

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study GroupR P Tonino, P J Meunier, R Emkey, et al.
The New England Journal of Medicine|March 19, 2004
Ten years' experience with alendronate for osteoporosis in postmenopausal womenHenry G Bone, David Hosking, Jean-Pierre Devogelaer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 19, 2022
COVID-19-mediated patient delay caused increased total ischaemic time in ST-segment elevation myocardial infarctionH N Sturkenboom, V A E van Hattem, W Nieuwland, et al.
Aging (Milan, Italy)|April 4, 2000
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study GroupT Schnitzer, H G Bone, G Crepaldi, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 27, 2017
Current MitraClip experience, safety and feasibility in the NetherlandsZ Rahhab, F A Kortlandt, J F Velu, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study GroupR P Tonino, P J Meunier, R Emkey, et al.
The New England Journal of Medicine|March 19, 2004
Ten years' experience with alendronate for osteoporosis in postmenopausal womenHenry G Bone, David Hosking, Jean-Pierre Devogelaer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 19, 2022
COVID-19-mediated patient delay caused increased total ischaemic time in ST-segment elevation myocardial infarctionH N Sturkenboom, V A E van Hattem, W Nieuwland, et al.
Aging (Milan, Italy)|April 4, 2000
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study GroupT Schnitzer, H G Bone, G Crepaldi, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 27, 2017
Current MitraClip experience, safety and feasibility in the NetherlandsZ Rahhab, F A Kortlandt, J F Velu, et al.
Pageof 3